Income Taxes (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Tax Credit Carryforward [Line Items] | |||
| Income tax examination description | The Company is subject to taxation in the United States at both the federal level and within Florida. The company is not currently under any audit examination. The federal and state statute of limitations is still open to the extent of the net operating losses generated within each particular year. Generally, U.S. and Florida tax years beginning in 2022 and forward remain open to examination, while Australian Taxation Office review periods remain open for 2024 and subsequent tax years. | ||
| Effective income tax rate continuing operations | 1.37% | ||
| Effective income tax rate continuing operations | 1.36% | 0.00% | |
| Operating loss carryforwards federal | $ 164,834,118 | ||
| Operating loss carryforwards state and local | 138,451,933 | ||
| Income tax reconciliation tax credits research | 0 | $ 0 | |
| Unrecognized Tax Benefits | 3,959,813 | $ 4,041,694 | $ 4,169,354 |
| Research and Development [Member] | |||
| Tax Credit Carryforward [Line Items] | |||
| Tax credit carryforward amount | $ 3,959,813 | ||
| X | ||||||||||
- Definition Effective income tax rate continuing operations. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrecognized tax benefits. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|